CW
REGN icon

Connectus Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Connectus Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.71M Buy
1,774
+672
+61% +$639K 0.05% 200
2023
Q4 		$969K Buy
+1,102
New +$907K 0.02% 333
2023
Q1 		– Sell
-1,195
Closed -$862K – 459
2022
Q4 		$862K Buy
1,195
+73
+7% +$53.9K 0.02% 300
2022
Q3 		$773K Buy
1,122
+73
+7% +$45.9K 0.02% 362
2022
Q2 		$620K Buy
1,049
+155
+17% +$101K 0.01% 316
2022
Q1 		$565K Sell
894
-25
-3% -$15.8K 0.02% 298
2021
Q4 		$580K Buy
+919
New +$565K 0.02% 261

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Connectus Wealth's REGN Position: Q1 2024 in Review

Connectus Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 61% in Q1 2024, buying an estimated $639K and bringing the position to 1,774 shares worth $1.71M. The position accounts for 0.05% of the portfolio, ranked #200.

Connectus Wealth first reported a position in REGN in Q4 2021 and has held it in 7 quarters since. 1,309 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Connectus Wealth held 1,774 shares of Regeneron Pharmaceuticals worth $1.71M as of Q1 2024.
  • Connectus Wealth bought 672 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $639K.
  • Regeneron Pharmaceuticals made up 0.05% of Connectus Wealth's portfolio in Q1 2024, its #200 holding.
  • Connectus Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 7 quarters since.
  • 1,309 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.